
- /
- Supported exchanges
- / US
- / THOXF.PINK
BioPorto A/S (THOXF PINK) stock market data APIs
BioPorto A/S Financial Data Overview
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get BioPorto A/S data using free add-ons & libraries
Get BioPorto A/S Fundamental Data
BioPorto A/S Fundamental data includes:
- Net Revenue: 34 906 K
- EBITDA: -61 821 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-20
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioPorto A/S News

BioPorto Announces Interim Results for the First Six Months of 2023
BioPorto A/S August 1, 2023 Announcement no. 14 BioPorto Announces Interim Results for the First Six Months of 2023 COPENHAGEN, Denmark and BOSTON, MA, USA, August 1, 2023, (GLOBE NEWSWIRE) -- Bio...


BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call
BioPorto A/S July 7, 2023 News Release BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call COPENHAGEN, Denmark and BOSTON, MA, USA, July 7, 2023, (GLOBE NEWSWIRE) -- BioPort...

BioPorto Announces Submission of Response to FDA Additional Information Letter
BioPorto A/S June 29, 2023 News release BioPorto Announces Submission of Response to FDA Additional Information Letter COPENHAGEN, DENMARK and BOSTON, MA, June 29, 2023, (GLOBE NEWSWIRE) -- BioPor...

Managers’ transactions
BioPorto A/S June 28, 2023 Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in company announcement no. 12, BioPorto A/S ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.